Is inflammation a contributor for coronary stent restenosis?

Medical Hypotheses

Volumn 68, Issue 5, 2007, Pages 945-951

  Li, Jian Jun ^a   Nie, Shao Ping ^b   Zhang, Chao Yang ^a   Gao, Zhan ^a   Zheng, Xin ^a   Guo, Yuan Lin ^a  

^a FUWAI HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CYTOKINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CORONARY STENT; CYTOKINE PRODUCTION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFLAMMATION; INFLAMMATORY CELL; INTIMA; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; STIMULUS RESPONSE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; STENTS; TUNICA INTIMA;

EID: 33847023000     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.05.069     Document Type: Article

References (44)

1. Al Suwaidi J., Berger P.B., and Holmes Jr. D.R. Coronary artery stent. JAMA 284 (2000) 1828-1836
2. Sigwart U., Puel J., Mirkovitch V., et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316 (1987) 701-706
3. Al Suwaidi J., Holmes Jr. D.R., Salam A.M., et al. Impact of coronary artery stent on mortality and nonfatal myocardial infarction: Meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J 147 (2004) 815-822
4. Xu Bo., Li J.-J., Yang Y.-J., et al. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han population. Chin Med J 119 (2006) 533-538
5. Li J.-J., Xu B., Yang Y.-J., et al. Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to paclitaxel-eluting stent. Chin Med J 119 (2006) 1059-1064
6. Alfonso F., Zueco J., Cequier A., Mantilla R., Bethencourt A., et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 42 (2003) 796-805
7. Bauthers C., Banos J.L., Van Belle E., et al. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation 97 (1998) 318-321
8. Mahdi N.A., Pathan A.Z., Harrell L., et al. Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. Am J cardiol 82 (1998) 1345-1351
9. Mehran R., Mintz G.S., Satler L.F., et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. Circulation 101 (2000) 2484-2489
10. Bennett M.R. In-stent restenosis: Pathology and implications for the development of drug eluting stent. Heart 89 (2003) 218-224
11. Karthikeyan G., and Bhargava B. Prevention of restenosis after coronary angioplasty. Curr Opin Cardiol 19 (2004) 500-509
12. Hirshfeld Jr. J.W., Schwartz J.S., Jugo R., et al. Restenosis after coronary angioplasty: A multivariant statistical model to relate lesion and procedure variables to restenosis. The M-HEART investigators. J Am Coll Cardiol 18 (1991) 647-656
13. Elezi S., kastrati A., Neumann F.J., et al. Vessel size and long-term outcome after coronary stent placement. Circulation 98 (1998) 1875-1880
14. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
15. Lowe H.C., Oesterle S.N., and Khachigian L.M. Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol 39 (2002) 183-193
16. Sobel B.E. Acceleration of restenosis by diabetes: Pathogenetic implications. Circulation 103 (2001) 1185-1187
17. Schomig A., Kastrati A., Elezi S., et al. Bimodal distribution of angiographic measures of restenosis six month after coronary stent placement. Circulation 96 (1997) 3880-3887
18. Ribichini F., Steffenino G., Delavalle A., et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: A major risk factor nad a marker of risk for coronary stent restenosis. Circulation 97 (1998) 147-154
19. van Bockxmeer F.M., Mamotte C.D., Gibbons F.A., et al. Angiotensin-converting enzyme and apolipoprotein E genotype and restenosis after coronary angioplasty. Circulation 92 (1995) 2006-2071
20. Kastrati A., Schomig A., Seyfarth M., et al. PIA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 99 (1999) 1005-1010
21. Tiroch K., von Beckerath N., Koch W., et al. Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting. Atherosclerosis 182 (2005) 145-151
22. Koch W., Tiroch K., von Beckerath N., et al. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine 24 (2003) 161-171
23. De Servi S., Mazzone A., Ricevuti G., et al. Granulocyte activation after coronary angioplasty in humans. Circulation 82 (1990) 140-146
24. Ferrester J.S., Fishbein M., Helfant R., et al. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J Am Coll Cardiol 17 (1991) 758-769
25. Neuman F.J., Ott I., Gawaz M., et al. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 27 (1996) 819-824
26. Aggarwal A., Blum A., Schender D.J., et al. Soluble CD40 ligand is an early initiator of inflammation after coronary intervention. Coron Artery Dis 15 (2004) 471-475
27. Li J.-J., Fang C.-H., Jaing H., et al. Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis. Angiology 55 (2004) 479-484
28. Gach O., Biemar C., Nys M., et al. Early release of neutrophil markers of activation after direct stenting in patients with unstable angina. Coron Artery Dis 16 (2005) 59-65
29. Paroli M., Mariani P., Accapezzato D., et al. Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization. Clin Immunol 112 (2004) 78-84
30. Hojo Y., Ikeda U., katsuki T., et al. Interleukin-6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 84 (2000) 83-87
31. Inoue T., Uchida T., Yaguchi I., et al. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 107 (2003) 1757-1763
32. Koster R., Vieluf D., Kiehn M., et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356 (2000) 1895-1897
33. Sardella G., Mariani P., D'Alessander M., et al. Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thromb Res 117 (2006) 659-664
34. Versaci F., and Gaspardone G. Prevention of restenosis after stenting: The emerging role of inflammation. Coron Artery Dis 15 (2004) 307-311
35. Li J.-J. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease. Med Hypotheses 62 (2004) 499-506
36. Li J.-J., Fang C.-H., Jiang H., et al. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal artery stenosis. Clin Chim Acta 350 (2004) 115-121
37. Gaspardone A., Crea F., Versaci F., et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 82 (1998) 515-518
38. Kozinski M., Krzewina-Kowalska A., Kubica J., et al. Percutaneous coronary intervention trigger a systemic inflammatory response in patients treated for in-stent restenosis: Comparison with stable and unstable angina. Inflamm Res 54 (2005) 187-193
39. Gomma A.H., Hirschfield G.M., Gallimore Jr. J.R., et al. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J 147 (2004) 945-947
40. Blum A., Schneider D.J., Sobel B.E., and Dauerman H.L. Endothelial dysfunction and inflammation after percutaneous coronary intervention. Am J Cardiol 94 (2004) 1420-1423
41. Yazdani S., Simon A.D., Vidhun R., et al. Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. Am Heart J 136 (1998) 357-361
42. Saleh N., Svane B., Jensen J., et al. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J 149 (2005) 876-882
43. Suzuki T., Kopia G., Hayashi A., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
44. Gogo Jr. P.B., Schneider D.J., Watkins M.W., et al. Systemic inflammation after drug-eluting stent placement. J Thromb Thrombolysis 19 (2005) 87-92